Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pengda Liu

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Oncotarget|December 12, 2012
Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2Zhiwei Wang, Hiroyuki Inuzuka, Jiateng Zhong, et al.
Science Signaling|January 4, 2022
DNA-PK promotes activation of the survival kinase AKT in response to DNA damage through an mTORC2-ECT2 pathwayLiu Liu, Xiaoming Dai, Shasha Yin, et al.
Current Pharmaceutical Design|November 16, 2012
Cdc20: a potential novel therapeutic target for cancer treatmentZhiwei Wang, Lixin Wan, Jiateng Zhong, et al.
Nature Communications|June 21, 2024
Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcomaLe Yu, Yu Deng, Xiaodong Wang, et al.
Biochimica Et Biophysica Acta|October 4, 2011
Skp2: a novel potential therapeutic target for prostate cancerZhiwei Wang, Daming Gao, Hidefumi Fukushima, et al.
Angewandte Chemie (International Ed. in English)|June 22, 2026
Enhancing Built-in Electric Fields in Covalent Organic Frameworks With High Surface Area and High Stability for Boosted Photocatalytic ActivityMingming Xu, Pengda Liu, Thien D Duong, et al.
Frontiers in Oncology|January 27, 2012
Skp2 is a promising therapeutic target in breast cancerZhiwei Wang, Hidefumi Fukushima, Hiroyuki Inuzuka, et al.
Journal of the American Chemical Society|April 11, 2025
(GGAA)<sub>3</sub>-Based TF-PROTACs Enable Targeted Degradation of ETV6 to Inhibit Ewing Sarcoma GrowthZhichuan Zhu, He Chen, Xing Qiu, et al.
Cell Research|May 15, 2013
Regulation of APC(Cdh1) E3 ligase activity by the Fbw7/cyclin E signaling axis contributes to the tumor suppressor function of Fbw7Alan W Lau, Hiroyuki Inuzuka, Hidefumi Fukushima, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 19, 2011
The two faces of FBW7 in cancer drug resistanceZhiwei Wang, Hidefumi Fukushima, Daming Gao, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Oncotarget|December 12, 2012
Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2Zhiwei Wang, Hiroyuki Inuzuka, Jiateng Zhong, et al.
Science Signaling|January 4, 2022
DNA-PK promotes activation of the survival kinase AKT in response to DNA damage through an mTORC2-ECT2 pathwayLiu Liu, Xiaoming Dai, Shasha Yin, et al.
Current Pharmaceutical Design|November 16, 2012
Cdc20: a potential novel therapeutic target for cancer treatmentZhiwei Wang, Lixin Wan, Jiateng Zhong, et al.
Nature Communications|June 21, 2024
Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcomaLe Yu, Yu Deng, Xiaodong Wang, et al.
Biochimica Et Biophysica Acta|October 4, 2011
Skp2: a novel potential therapeutic target for prostate cancerZhiwei Wang, Daming Gao, Hidefumi Fukushima, et al.
Angewandte Chemie (International Ed. in English)|June 22, 2026
Enhancing Built-in Electric Fields in Covalent Organic Frameworks With High Surface Area and High Stability for Boosted Photocatalytic ActivityMingming Xu, Pengda Liu, Thien D Duong, et al.
Frontiers in Oncology|January 27, 2012
Skp2 is a promising therapeutic target in breast cancerZhiwei Wang, Hidefumi Fukushima, Hiroyuki Inuzuka, et al.
Journal of the American Chemical Society|April 11, 2025
(GGAA)<sub>3</sub>-Based TF-PROTACs Enable Targeted Degradation of ETV6 to Inhibit Ewing Sarcoma GrowthZhichuan Zhu, He Chen, Xing Qiu, et al.
Cell Research|May 15, 2013
Regulation of APC(Cdh1) E3 ligase activity by the Fbw7/cyclin E signaling axis contributes to the tumor suppressor function of Fbw7Alan W Lau, Hiroyuki Inuzuka, Hidefumi Fukushima, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 19, 2011
The two faces of FBW7 in cancer drug resistanceZhiwei Wang, Hidefumi Fukushima, Daming Gao, et al.
Pageof 9